Table 1 Baseline characteristics of the four groups
| Â | Group 1: Donor and recipient non-marginal | Group 2: Donor non- marginal, recipient marginal | Group 3: Donor marginal, recipient non- marginal | Group 4: Donor and recipient marginal | P-value |
|---|---|---|---|---|---|
No. of patients | 138 | 41 | 69 | 84 | - |
Females (%) | 55 (39.9%) | 20 (48.8%) | 30 (43.5%) | 28 (33.3%) | 0.359 |
Recipient age (years) | 42.7 ± 10.4 | 61.8 ± 5.0 | 42.7 ± 10.1 | 64.5 ± 5.1 | < 0.001 |
Recipient body mass index (kg/m2) | 24.7 ± 4.6 | 25.5 ± 4.0 | 23.9 ± 3.5 | 25.4 ± 3.8 | 0.102 |
Recipient comorbidity | Â | Â | Â | Â | Â |
   Arterial hypertension | 14 (10%) | 5 (12%) | 9 (13%) | 4 (5%) | 0.325 |
   Arteriosclerotic disease | 15 (11%) | 19 (46%) | 7 (10%) | 26 (31%) | < 0.001 |
   Heart insufficiency | 10 (7%) | 4 (10%) | 2 (3%) | 8 (10%) | 0.387 |
   Diabetes mellitus | 11 (8%) | 14 (34%) | 3 (4%) | 15 (18%) | < 0.001 |
   Thyroid disease | 9 (7%) | 2 (5%) | 7 (11%) | 9 (11%) | 0.528 |
   Secondary hyperparathyreoidism | 91 (66%) | 24 (60%) | 44 (66%) | 54 (68%) | 0.907 |
   Tertiary hyperparathyreoidism | 8 (6%) | 3 (8%) | 4 (6%) | 2 (3%) | 0.907 |
   Hypercholesterolemia | 18 (13%) | 8 (20%) | 14 (20%) | 33 (40%) | < 0.001 |
   Chronic obstructive lung disease | 8 (6%) | 2 (5%) | 2 (3%) | 5 (6%) | 0.808 |
Duration of dialysis (months) | 72 (42) | 67 (36) | 86 (55) | 63 (35) | 0.007 |
First transplantation | 101 (73%) | 34 (83%) | 50 (73%) | 66 (79%) | 0.802 |
HLA-DR mismatches (0/1/2) | 46 (33%) | 14 (34%) | 26 (38%) | 18 (21%) | Â |
| Â | 60 (43%) | 15 (37%) | 28 (41%) | 32 (38%) | 0.083 |
| Â | 32 (23%) | 12 (29%) | 15 (22%) | 34 (41%) | Â |
Same gender transplantation | 60 (44%) | 21 (51%) | 35 (53%) | 47 (56%) | 0.571 |